Concepedia

Mary Allen

MA

43

Publications

2.8K

Citations

28

H-Index

1999

Active since

Affiliations

Fred Hutch Cancer Center(Current)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Perinatal HIV Research Unit

University of Cape Town

Mary Allen is an author at Fred Hutch Cancer Center specializing in medicine, vaccination, and hiv.

ORCID

Top concepts

Publications per year

1999–2025

43

Publications

43

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Glenda Gray, Mary Allen, Zoe Moodie et al. · The Lancet Infectious Diseases · 2011 · 382 citations · Full text

, , +9

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

Glenda Gray, Linda‐Gail Bekker, Fatima Laher et al. · New England Journal of Medicine · 2021 · 221 citations · Full text

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Spyros A. Kalams, Scott Parker, Marnie Elizaga et al. · The Journal of Infectious Diseases · 2013 · 193 citations · Full text

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial

Kenneth H. Mayer, Kelly E. Seaton, Yunda Huang et al. · PLoS Medicine · 2017 · 129 citations · Full text

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg et al. · The Lancet HIV · 2018 · 121 citations · Full text

Rows per page

1–5 of 43